Advertisements



Mallinckrodt reports retrospective analysis on Phase 3 REVERSE trial data at ILC

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2019

Graybug Vision reports full-data analysis from ALTISSIMO phase 2b trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 12th, 2021

Tonix Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational Highlights

50% of Enrollment Complete for Phase 3 RECOVERY Trial of Tonmya® for the Treatment of PTSD Results from RECOVERY Interim Analysis Expected First Quarter 2020 Topline Data Expected Second Quarter 2020 Based on Cu.....»»

Category: earningsSource: benzingaNov 8th, 2019

Adaptimmune reports initial data from Phase 2 SPEARHEAD-1 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 19th, 2021

Regenxbio reports interim data from Phase I/II trial of RGX-12

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 14th, 2021

Applied Genetic reports data from the ongoing XLRP phase 1/2 clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 6th, 2021

Syndax reports updated data from Phase 1 AUGMENT-101 trial of SNDX-5613

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 20th, 2021

Cellect Biotechnology reports data from Phase 1/2 clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 19th, 2021

Altimmune reports data from phase 1B clinical trial of NasoShield

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 1st, 2021

Imara reports Phase 2a open label extension clinical trial data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 5th, 2021

Evelo Biosciences reports confirmatory data from Phase 1b trial of EDP1815

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 20th, 2021

Accuray reports data from phase II trial using TomoTherapy System

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 19th, 2021

Freeline reports updated data from Phase 1/2 B-AMAZE trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 14th, 2020

Galera reports Phase 2b trial data to be presented at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 13th, 2020

Evelo Biosciences Reports First Quarter Financial Results and Business Highlights

–Submitted investigational new drug (IND) application for a Phase 2 trial of EDP1815 for COVID-19; data readout expected during.....»»

Category: earningsSource: benzingaMay 11th, 2020

Selecta Biosciences Reports First Quarter 2020 Financial Results

- Topline data announcement from the ongoing head-to-head COMPARE trial of SEL-212 remains on schedule for Q3 2020 - - Phase 3 clinical program of SEL-212 to com.....»»

Category: earningsSource: benzingaMay 7th, 2020

Merck reports interim data from Cohort B of KEYNOTE-555 Phase 1 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 27th, 2020

AstraZeneca presents new data from sub-analysis of Phase III DAPA-HF trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 28th, 2020

Fulcrum reports complete data from Phase 1 trial with Losmapimod in FSHD

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 24th, 2020

Sun BioPharma Provides Business Update and Reports Operating Results for FY2019

Enrollment completed in fourth cohort of Phase 1a/1b trial of SBP-101 in pancreatic cancer; expansion cohort initiated Interim Phase 1 data presented a.....»»

Category: earningsSource: benzingaMar 24th, 2020

Salarius Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results

Seclidemstat Achieves Dose-Escalation Milestone in Phase 1/2 Ewing Sarcoma Clinical Trial Sixth Level Dosing Cohort Now Proceeding; On Track To Report Topline Data in 2020 HOUSTON, March 23, 2020 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc.....»»

Category: earningsSource: benzingaMar 23rd, 2020